Established Icon
Milestones

Milestones

From a visionary start in 1988 to becoming a global pioneer in evidence-based health science, Sabinsa’s milestones reflect our commitment to innovation, research, and wellness.

2023

2023

  • Industry Outlook names Sami-Sabinsa Group as one of the "Top 10 Food Ingredient & Additive Manufacturers" for 2023
  • Sabinsa Celebrates 35th Anniversary
  • Sabinsa Opens Office in France, Appoints Ms. Nathalie Allaume as Sales Manager
  • Sabinsa Nanjing wins ‘2023 Technology Innovation Award’ for LactoSpore®
  • Sabinsa Corporation honored with “Varro E. Tyler Commercial Investment in Phytomedicinal Research” Award
  • Sami-Sabinsa Group Commits to Clean, Renewable Energy : Captive solar energy will power five manufacturing plants
  • Sabinsa Reaches Intellectual Property Milestone with Over 400 Granted Patents
2022

2022

  • Sami-Sabinsa Group Releases Book on “Selenium in Health and Diseases”
  • Sami-Sabinsa honoured with “Best Manufacturer Export Award 2022” by FKCCI
  • Sami-Sabinsa Group has been ranked as one of the Top 10 Pharma Laboratories in the year 2022 by India Pharma Outlook
  • Dr. Muhammed Majeed, Chairman and Founder of Sami-Sabinsa Group, was named the “Legend of the Millennium in Nutraceutical Industry” by ASSOCHAM for his outstanding contributions to the field of nutraceuticals.
  • In conjunction with the Global Ayush Investment & Innovation Summit 2022, Sami-Sabinsa signed a MoU with the farmers of J&K through the J&K Medicinal Plants Board.
  • Sami-Sabinsa Group signed a historic MoU with Manav Sadhan Vikas Sanstha (MSVS) for the cultivation of Garcinia indica plant used for the production of Livinol®.
  • Sami-Sabinsa Group attended the Joint Parliamentary Committee meeting on the Biological Diversity (Amendment) Bill, 2021 to discuss the impact of the amendment on the Nutraceutical Industry and possible ways forward.
  • Sabinsa has received Novel Food approval from the European Food Safety Authority (EFSA) for its patented Curcumin C3 Reduct®.
  • Sabinsa receives TGA Approval for use of LactoSpore® as listed medicine in Australia.
  • Sami-Sabinsa accomplishes Intellectual Property Milestone with over 400 plus Granted Patents (as of Dec 2022)
  • Sabinsa’s Cirpusins® shows its supporting role in healthy body composition and lipid metabolism
  • Indian Customs grants Sami-Sabinsa Group the Authorized Economic Operator (AEO) Tier–Two Certificate.
  • To support various CSR initiatives, Dr. Majeed Foundation contributed Rs. 4.88 Crores during the Financial Year 2021-2022.
2021

2021

  • Sabinsa’s Postbiotic LactoSporin® Wins 1st Place in NIE Awards
  • Sami-Sabinsa Names Dr. Umar Jan as President of European Operations
  • Sabinsa expands UK and EU footprint with new staff
  • Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
  • Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
  • Sabinsa’s New Research Evaluates Curcumin C3 Complex® and BioPerine® Combination for Its Supportive Role in Overall Immune and Respiratory Wellness
  • Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction for Discovery Abuses in Litigation
  • Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
  • New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
  • Sabinsa Top Scientist Gives Presentation to U.S. FDA
2020

2020

  • Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
  • Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
  • Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
  • Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
  • Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
  • Sabinsa Providing Glyphosate Test Results with Ingredients
  • Sabinsa Granted Patent in Mexico on Boswellin® PS Related to Supporting a Balanced Inflammatory Response
  • Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
  • Dr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
  • Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
  • Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
  • Research on Sabinsa’s Cosmeceutical LactoSporin® Among the First Published Human Clinical Studies on a Probiotic Metabolite Supporting Clear, Healthy-Looking Skin
  • Sabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
  • Sabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
  • Sabinsa Earns Non-GMO Project Verification for Eleven Key Ingredients
  • Sabinsa’s Curcumin C3 Complex® with BioPerine® Shown to help Improve Cytokine Level
  • Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
  • Sabinsa Warns Industry Against Mischaracterized Amla Extracts
  • Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
  • Two New Published Studies Highlight Cosmetic Benefits of Sabinsa’s pTeroWhite®, Including Support for Brighter, More Even-Looking Skin and Protection Against UV-Induced Skin Damage
  • Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
  • Sabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
  • Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
2019

2019

  • Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
  • Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming its role in supporting gut health and emotional well-being in individuals with digestive challenges
  • Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
  • Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
  • Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
  • Research evaluates Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® for Its Role in Supporting Liver Health and Metabolic Wellness
  • Sami-Sabinsa Honored with Multiple “Best of” Awards in New Delhi and Singapore
  • Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids
  • Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West
  • Pilot Study Published Examining Curcumin C3 Complex® and BioPerine® With in Research on Liver Cell Health
  • Study Shows Effects of Curcumin Curcumin C3 Complex® and BioPerine® Combination on Cellular Responses in Mesothelioma Research Models
  • Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
  • Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
  • New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® in Combination with Standard Medical Therapy
  • Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
  • Sabinsa Achieves USP GMP Audited Status for Three Additional Sites
  • Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
  • Sabinsa Shagandha™ Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs
  • Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development
  • Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair
  • Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
  • Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status
  • Sabinsa’s Manufacturing Arm Receives Research Funding From The Government of India
  • Published Analysis of Curcumin Research Provides Comprehensive Overview
2018

2018

  • Sami–Sabinsa Founder and Sami Labs Honored With Multiple Awards by Associated Chambers of Commerce & Industry of India for Outstanding Nutraceuticals Industry Achievement
  • Research on Curcumin’s Positive Effects on Microbiome Published Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to Researchers
  • Sami-Sabinsa Group Diversifies into Information Technology and Business Solutions With Expansion of Edkal Technologies to US
  • Sami-Sabinsa Honored By Pharmexcil For Export Excellence
  • Sabinsa’s Shelf Stable Probiotic LactoSpore® May Improve Cholesterol Levels, Study Suggests
  • Sami–Sabinsa Honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
  • Sabinsa’s Nigellin™ Black Cumin Seed Extract Identified as having a favorable influence on markers related to immune balance, based on studies conducted in models of respiratory health
  • Sabinsa Signs Memorandum of Understanding with Japan External Trade Organization at Summit With Prime Ministers of India and Japan
  • Sabinsa Opens Toronto Office to Support Canadian Customers and Market
  • Sami-Sabinsa Group FSMA Implementation Update: 14 Staff PCQI Certified
  • Sabinsa Honored with Two Prestigious Awards Acknowledging the Significance of the Company’s Cultivation and Reforestation Programs
  • Sami-Sabinsa Group Scientists Publish Research on Flow Cytometry as an Effective Test Method to Assess Viable Spore Count in LactoSpore®
  • Sami-Sabinsa Group Acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicum
  • Sami-Sabinsa’s Pterocarpus marsupium Reforestation Program Named Industry Initiative of The Year Award Finalist
  • Sami-Sabinsa Recognized For Export Achievement by Federation of Karnataka Chambers of Commerce & Industry
  • Sabinsa’s Legal Victory Over Olive Lifesciences for Patent Infringement Profiled in Prominent Law Journal
  • Sami Labs – Sabinsa Hyderabad Facility Receives NSF GMP Certification
  • Sami-Sabinsa Founder Dr. Muhammed Majeed named NutraChampion
  • Sabinsa parent company Sami Labs honored with outstanding export award
  • Sabinsa successfully protects its Curcumin C3 Reduct® technology
  • Tufts – Tohoku study on curcumin + piperine combination verifies Sabinsa’s research on synergistic properties
  • Sabinsa announces 10 year reforestation commitment to Pterocarpus marsupium cultivation
  • Sabinsa and Eurofins enter into global ID testing agreement for proprietary ingredient
2017

2017

  • New patents granted to Sabinsa’s cosmetics division in US and EU
  • Sabinsa granted US patent for synbiotic composition of LactoSpore® shelf stable probiotic and cranberry fibers
  • Sabinsa publishes scientific compendium on BioPerine® black pepper extract
  • Shaheen Majeed named Sabinsa President worldwide
  • Sabinsa successfully protects its Curcumin C3 Reduct® technology
  • Sabinsa’s Curcumin C3 Complex® with BioPerine® supporting healthy lipid profiles in type 2 diabetes in published study
  • Court orders olive lifesciences to pay sabinsa $2.2 million for willfull infringement
  • Sabinsa granted US patent on LactoSpore® for IBS support
  • Sabinsa’s Curcumin C3 Complex® studied for antioxidant effect in diabetes patients
  • Sabinsa’s DigeZyme® study shows it helped support for delayed onset muscle soreness in published study
2016

2016

  • Sabinsa’s Boswellin® Super reported in japanese study helped support knee comfort and mobility in participants
  • European journal publishes article on Sami / Sabinsa oil control moisturizer safety and efficacy
  • Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent
  • Sabinsa’s Curcumin C3 Complex® in combination with Omega-3s found to have synergistic effect
  • Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
  • Sabinsa receives approval for New Health Claims on Curcumin C3 Complex® and Curcumin C3 Reduct® in Canada
  • Sabinsa successfully defended its proprietary rights for “Boswellin”
  • Sabinsa achieves significant canadian health claim on IBS support of shelf-stable probiotic LactoSpore®
  • Sami-Sabinsa recognized by global health & pharma as the best international life science company and most innovative inflammatory condition support ingredients
  • Sabinsa’s parent company Sami Labs recognized for excellence in research and development
  • Sabinsa / Sami Labs recognized for export excellence by Karnataka government trade promotion center
  • New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®
  • Sabinsa defends Tetrahydrocurcuminoids patent with legal action
  • A clinical study by the university of georgia found that Resveratrol fortified with Sabinsa’s BioPerine® helped support healthy mitochondrial function
  • Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics
  • Metabolic syndrome study on Sabinsa’s Curcumin C3 Complex® honored with university research of the year award
  • Sabinsa receives "no questions” letter from the us FDA on GRAS status for LactoSpore®
  • Muhammed Majeed, Ph.D. honored as industry legend and inducted into the Hall of Legends at Natural Products Expo West, 2016
  • Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents, and recently added 15 new patents
  • Stability research published on Sabinsa’s LactoSpore® shelf stable probiotic for functional foods
  • Cumulative safety data of ForsLean®, the company’s patented coleus forskohlii extract, published in an International Scientific Journal
2015

2015

  • Sabinsa’s LactoSpore® Human Safety Study Cleared For Health Canada Access
  • Sabinsa Patent Infringement Litigation Against Prakruti Settled: Curcumin C3 Complex® Patent Successfully Defended
  • Sabinsa Launches New, Nano-Free Water Soluble Curcumin Form: uC3 Clear™
  • Sami Labs Recognized With Two State Export Excellence Awards By Visvesvaraya Trade Promotion Centre, Karnataka, India
  • Sabinsa once more successfully protects Curcumin C3 Complex® patent infringement litigation against Herbakraft settled
  • Sabinsa Awarded Four New Us Patents: Patent Portfolio Total Climbs To 95
  • Sabinsa expands herb cultivation program founder promotes sustainability, advocates cultivation to protect India’s herbal legacy
  • Sabinsa’s Curcumin C3 Complex® Shows Significant Benefits in healthy levels of Lipid Levels in Patients With Coronary Artery Disease
  • UK Study Shows Sabinsa’s Curcumin C3 Complex® alongside standard medical therapy, exploring its safety profile and its potential role in supporting overall health during treatment
  • Sabinsa / Sami Labs Recognized With Award For Export Excellence By Karnataka Chamber of Commerce
  • Sabinsa’s Utah Facility Receives Foreign Site Registration Number From Canada
  • Shaheen Majeed Appointed To Sami Labs Group Board Of Directors
  • Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
  • Curry Powder To Clinical Significance: New book provides a comprehensive understanding of curcumin & studies on Curcumin C3 Complex®
  • Sabinsa Victorious In Litigation Against Nutribiolink For Curcumin C3 Complex® Patent Infringement
2014

2014

  • Sabinsa adds four new patents, bringing world wide portfolio to 91
  • C3 Reduct® wins Functional Ingredients editors choice award for best science
  • Sami and Sabinsa receive Best New Product Excellence Award in the raw material category at Panacea-Natural roduct Expo India for Saberry®
  • Sabinsa / Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS)
  • Sabinsa / Sami Labs receives two pharmexcil awards for 2012 – 2013 in the herbals, ayurveda & nutraceuticals category: The gold award for patents and the silver award for exports in herbals
  • Former President of India visits Sami Labs (late A.P.J. Abdul Kalam)
  • Sabinsa introduces new form of coleus with ForsLean® Soft Extract
  • Study shows Boswellia® cream may help reduce the appearance of redness and support soothed, comfortable skin
  • Sabinsa initiates lawsuit against four companies for Curcumin C3 Complex® patent infringement
  • Iranian clinical study shows combination of C3 Complex® and BioPerine® supports joint comfort and mobility among osteoarthritis patients
  • Sabinsa Launches Animal Nutrition Division: Vetvitals®
  • Sabinsa’s Curcumin C3 Complex® and BioPerine® combination used in metabolic health study
  • Sabinsa/Sami Labs acquires KCP Biotech, expands capacity and adds more colors
  • Sabinsa teams up with Fruit D’Or to launch LactoSpore®-Cranberry combination LactoCran™
  • Sabinsa’s LactoSpore® moves into cosmeceuticals with topical Candida products
2013

2013

  • Next generation of curcumin launched, resolving potency, color, dosage, stability and bioavailability concerns, called Curcumin C3 Reduct®
  • Recipient of Frost & Sullivan’s 2013 North American Integrated Prebiotic Delivery Technology Innovation Award
  • United States patent granted on a unique weight management formula
  • United States patent granted for a natural preservative, SabiLize®
  • Sabinsa Utah Facility Earns NSF Good Manufacturing Practices (GMP) Registration
  • Sabinsa on Wheels returns to USA, three major states selected and presented at Utah, California, and New Jersey
  • Sabinsa’s Curcumin Receives GRAS No Comment Letter From FDA
  • Sabinsa's Sami Labs named product Innovator Of The Year
  • Sabinsa’s LactoSpore® Inspires Gluten-Free Expert To Create Gourmet Cookies
  • Sabinsa Launches D’Cosmix Range Of Dermaceutical Composites At International Exhibitions
  • Sabinsa Breaks Ground On Additional Facility, Increasing Production 200%
2012

2012

  • Curcumin C3 Complex® wins Functional Ingredients editor's choice award in the marketing category
  • Sabinsa’s LactoSpore® Chosen For Tutti Frutti, World’s Top Selling Self-Serve Frozen Yogurt
  • The first non-diary use of Sabinsa’s Shelf-Stable Probiotic, LactoSpore®, can be found in Colombia’s Perman Bread
  • New Study says Sabinsa's Curcumin C3 Complex® shows support for maintaining healthy triglyceride levels
  • Sabinsa Publishes Book on Tetrahydrocurcuminoids
  • Sabinsa on Wheels held for the first time in Seoul, South Korea
  • Sabinsa wins patent in Japan for coleus derived ocular health product
2011

2011

  • Sami Labs inks Research Collaboration Agreement with National Institute of Medicinal Materials (NIMM), Ministry of Health, Vietnam for Research & Development of Vietnamese Traditional Medicinal Plants
  • Sabinsa Introduces Integrated Nutritional Composites™ (Inc) Bilayered Tablets
  • Sabinsa’s BioPerine® Validated In Resveratrol Pre-Clinical Study
  • Sabinsa Global Expansion Continues: Opens Offices In Korea
  • Sabinsa Receives Top Pharmexcil Award
  • Sabinsa R&D Named Best Innovation And Technology Company
2010

2010

  • Sami's Kunigal plant near Bangalore, India received NSF (National Sanitation Foundation) GMP certification
  • Received the first patent in China for "Process For Preparing Water Soluble Diterpenes And Their Applications"
  • Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian market
  • Sami's Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification
2009

2009

  • Sabinsa received the 2009 Herbal Industry Leader Award from the American Herbal Products Association
  • Sabinsa received its 57th patent and it is the first patent from Russia
2008

2008

  • NABL accreditation for laboratories of Sami Labs Limited
  • Continuous Extraction plant commissioned by Sami Labs Limited in Bangalore
2007

2007

  • Sabinsa sets up its office in South Africa
2006

2006

  • Forskolin Eye Drops approved by DCGI for Glaucoma
  • Sabinsa Europe GmBH was set up in Langen, near Frankfurt in Germany
2005

2005

  • Received two patents for Tetrahydropiperine
  • Received the second Thomas Alva Edison Patent Award for 2005
2004

2004

  • Sabinsa's US Patent for ForsLean® received the Thomas Alva Edison Patent Award for 2004
  • Dr. Majeed was conferred the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations (NECO)
2003

2003

  • MGP Herbal (P) Ltd was acquired to facilitate and co-ordinate Herbal Cultivation - a major step that helped provide jobs to several farmers in India
2002

2002

  • Super-Critical Fluid Extraction facility set up at Nelamangala
  • The R & D Centre of Sami Labs Limited, Bangalore received the DSIR Award for its R & D efforts
2001

2001

  • First weight Management product ForsLean® was voted as the Best New Product of the year by Nutraceutical Industry Association – Nutracon in the US
  • Sabinsa received its first European patent on Curcuminoids
  • Sabinsa Japan Corporation was started
2000

2000

  • Biotechnology Center established at Nelamangala, Bangalore
  • Tetrahydrocurcuminoids, also referred to as “White Curcumin” was introduced as a skin lightener into the US market
1998

1998

  • Sami Chemicals and Extract Pvt. Ltd. – name was changed to Sami Labs Limited to reflect more accurately its current activities
1997

1997

  • New Jersey Technology Fast 50 Award
  • Sabinsa listed again in the Inc 500 companies, ranking # 90
  • Award for Export Performance for Spice products from President of India
1996

1996

  • Sabinsa was listed in the Inc 500 companies, ranking # 70
  • First US patent awarded for the product BioPerine® was awarded to Sabinsa Corporation
  • An Export-Oriented manufacturing unit is established at Kunigal, Bangalore
1993 – 95

1993 – 95

  • Standardization of Indian herbal medicines by Sami research group
  • Sabinsa started the “Sabinsa on Wheels” program also know as SOW. Here the Sabinsa team endeavors to share its knowledge to a large group of professionals and common man on its diverse range of products
1991

1991

  • Sami Chemicals and Extracts Pvt Ltd set up in Bangalore
1988

1988

  • Sabinsa Corporation, New Jersey USA was setup
Possibilities Background

Explore endless possibilities with us.
Let’s connect and make it happen!

Get In Touch